Table 3.
Data collection schedule
| Follow-up | |||||||
|---|---|---|---|---|---|---|---|
| Inclusion | Preop SRS | Surgery | M3 | M6 | M9 | M12 | |
| Consent | ✓ | ||||||
| Medical and surgical history | ✓ | ||||||
| History of the disease | ✓ | ||||||
| DS GPA classification | ✓ | ||||||
| Serum Pregnancy Test (for woman of childbearing age) | ✓ | ||||||
| Clinical examination | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
| Previous and concomitant treatment | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
| Toxicity Evaluation (NCI CTCAE v5.0) | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
| MMSE and EORTC QLQ-C30 questionnaires | ✓ | ✓ | ✓ | ✓ | ✓ | ||
| Surgery information (date, quality of surgery and post-operative follow-up) | ✓ | ||||||
| Dosimetric brain MRI | ✓ | ||||||
| Dosimetric CT scan | ✓ | ||||||
| Tumor sample (FFPE block) | ✓ | ||||||
| Dose delivered to target volumes and organs at risk | ✓ | ||||||
| Paddick conformity Index and Gradient Index | ✓ | ||||||
| Brain MRI | ✓a | ✓ | ✓ | ✓ | ✓ | ||
a within 48 h postoperatively (scanner accepted if MRI is not available)